NS · Healthcare

Venmax Drugs & Pharmaceuticals Ltd (531015)

Pharmaceuticals & Biotechnology

Venmax Drugs & Pharmaceuticals Ltd (531015) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $194.60M, P/E ratio is 70.50, net margin is 11.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 531015

Market cap

$194.60M

P/E ratio

70.50

Net margin

11.7%

Venmax Drugs & Pharmaceuticals Ltd (531015) — FAQ

What is Venmax Drugs & Pharmaceuticals Ltd's market cap?

Venmax Drugs & Pharmaceuticals Ltd (531015) has a reported market cap of $194.60M (data as of 2026-07-10).

What is 531015's P/E ratio?

The price-to-earnings (P/E) ratio for Venmax Drugs & Pharmaceuticals Ltd (531015) is 70.50 (data as of 2026-07-10).

Does Venmax Drugs & Pharmaceuticals Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Venmax Drugs & Pharmaceuticals Ltd (531015). Check the MyAverix Finance app for the latest dividend data.

What sector is Venmax Drugs & Pharmaceuticals Ltd in?

Venmax Drugs & Pharmaceuticals Ltd (531015) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 531015 listed on?

531015 is listed on NS.

What is Venmax Drugs & Pharmaceuticals Ltd's net margin?

Venmax Drugs & Pharmaceuticals Ltd (531015) reports a net margin of 11.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)